On February 25, a research paper by Professor Ke Yang's research group from the Genetics Research Laboratory of Peking University Cancer Hospital was published online in Lancet's sub-journal

The nominated PCC targets biological targets that play a key role in DNA damage repair mechanisms, and is one of the four targets of interest proposed by Fosun Pharma when the collaboration was initiated.

DCS Lab is the first laboratory empowerment program of UW Smart for the global frontier research field, aiming to help the world's top researchers to build an international leading, scaled-up and standardized multi-omics frontier laboratory, and to open up more possibilities for the life science and technology industry.

As the first medical large model in China dedicated to the cardiovascular specialty, the system integrates multimodal diagnostic and treatment data with the expertise of top doctors, achieving full-process intelligence from medical history collection to assisted diagnosis.